Cleared Traditional

K220008 - Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange Catheter, ICY Intravascular Heat Exchange Catheter, Quattro Intravascular Heat Exchange Catheter, Thermogard HQ Start-Up Kit, Thermogard HQ Start-Up Kit EX, Thermogard HQ Console (FDA 510(k) Clearance)

Jun 2022
Decision
149d
Days
Class 2
Risk

K220008 is an FDA 510(k) clearance for the Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange Catheter, ICY Intravascular Heat Exchange Catheter, Quattro Intravascular Heat Exchange Catheter, Thermogard HQ Start-Up Kit, Thermogard HQ Start-Up Kit EX, Thermogard HQ Console. This device is classified as a System, Hypothermia, Intravenous, Cooling (Class II - Special Controls, product code NCX).

Submitted by Zoll Circulation, Inc. (San Jose, US). The FDA issued a Cleared decision on June 2, 2022, 149 days after receiving the submission on January 4, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 870.5900.

Submission Details

510(k) Number K220008 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received January 04, 2022
Decision Date June 02, 2022
Days to Decision 149 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code NCX - System, Hypothermia, Intravenous, Cooling
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.5900